Related Experiment Video
Updated: May 1, 2026

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
Published on: February 10, 2018
Hepatitis C and liver transplantation
G Tsoulfas1, I Goulis, D Giakoustidis
1Surgical Department of Transplantation, Aristotle University, Hippokratio General Hospital, Thessaloniki, Greece. tsoulfasg@msn.com
Abstract:
Cirrhosis due to chronic hepatitis C is the leading indication for liver transplantation in Europe, United States and Japan. Reinfection after liver transplantation is universal and chronic liver disease develops in at least 70% of patients at 3 years, with an accelerated course compared to the nontransplant setting. These facts underscore the need for a better understanding of hepatitis C infection and the various treatment modalities. This paper attempts a brief review of the scope of the disease, as well as the different treatment modalities, with special emphasis given to orthotopic liver transplantation.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction

